Geneial, Inc.
PrivateLast Round
Grant
Nov 1, 2023
Total Funding Raised
$2.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Geneial, Inc. operates in Healthcare & Life Sciences and is based in Missouri City, Texas. Its latest recorded funding round was a Grant round in November 2023.
Geneial, Inc. is a healthcare technology company that provides a precision medicine data infrastructure and patient engagement platform for rare and genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Precision Medicine, Data Integration, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Geneial, Inc. Comparables
Compare Geneial, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pulse Infoframe | 86% | |
| Across Healthcare | 79% | |
| Citizen Health | 77% |
For institutional investors. Book with your work email.
Geneial, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2023 | ||||
| Grant | Sep 22, 2022 | ||||
| Pre Seed | Jun 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Geneial, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Library of Medicine | Grant |
| NIH RADx | Grant |
| Creative Destruction Lab | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 44% MoM, reaching 2.8K.
- Mar 3, 2026
Monthly visitors increased 52% MoM.
For institutional investors. Book with your work email.
Geneial, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Geneial, Inc.'s valuation, stock price, and market status.
Is Geneial, Inc. a public or private company?
Geneial, Inc. is a private company.
What is the current stock price of Geneial, Inc.?
Geneial, Inc. is a private company, so its shares have no public market price. Caplight tracks Geneial, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Geneial, Inc. worth (valuation)?
Valuation information for Geneial, Inc. is not publicly available.
Can I buy Geneial, Inc. stock?
Geneial, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Geneial, Inc.'s last funding round?
Geneial, Inc.'s most recent funding round was Grant on November 1, 2023.
Who are the main investors in Geneial, Inc.?
Key investors in Geneial, Inc. include National Library of Medicine, Creative Destruction Lab.
Will Geneial, Inc. IPO soon?
No public IPO plans have been announced for Geneial, Inc..
How can I track Geneial, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Geneial, Inc.'s shares on secondary markets.